the aid library

LIST OPTIONS

Filter

5828

Sort by:

Direction:

Download (85)

View PDF (130)

Chronic HIV Care with ARV Therapy and Prevention

World Health Organization (2007) C_WHO

Integrated Management of Adolescent and Adult Illness Integrated Management of Childhood Illness Interim Guidelines for health workers at health centre or district hospital outpatient clinic

Download (2189)

View PDF (2454)

Treatment of Mycobacterium Ulcerans Disease (Buruli Ulcer)
recommended

World Health Organization WHO WHO (2012) C_WHO

Guidance for health workers

Download (503)

View PDF (469)

Isoniazid preventive therapy for children: impact on mortality and incidence of tuberculosis?

C. D. Mitchell World Health Organization (2013) C_WHO

HIV/TB Research Meeting; March 3, 2013

Download (163)

View PDF (253)

HEARTS. Technical package for cardiovascular disease management in primary health care. Systems of Monitoring

World Health Organization WHO, et al. (2018) C_WHO

Monitoring is a crucial element in any successful programme. It is important to know if health care facilities – and ultimately countries – are meeting the agreed goals and objectives for preventing and managing cardiovascular diseases (CVD). Monitoring is the on-going collection, management ...and use of information to assess whether an activity or programme is proceeding according to plan and/ or achieving defined targets. Not all outcomes of interest can be monitored. Clear outcomes must be identified that relate to the most important changes expected to result from the project and to what is realistic and measurable within the timescale of the project. Once these outcomes have been articulated, indicators can be chosen that best measure whether the desired outcomes are being met. To allow progress to be monitored, this module provides a set of indicators on CVD management. Agreeing on a set of indicators allows countries to compare progress in CVD management and treatment across different districts or subnational jurisdictions, as well as at a facility level, identify where performance can be improved, and track trends in implementation over time. Monitoring these indicators also helps identify problems that may be encountered so that implementation efforts can be redirected. This module starts from the collection of data at facility level, which is then “transferred up” the system: facility-level data are aggregated at subnational level to produce reports that allow tracking of facility and subnational performance over time and allow for comparison among facilities. National-level data are obtained through population-based surveys. Implementing a monitoring system requires action at many levels. At national and subnational levels, staff can determine how best to integrate data elements into existing data collection systems – such as the routine service-delivery data that are collected through facility-level Health Management Information Systems (HMIS). In the facility setting, personnel must be aware of what data are needed. Sample data-collection tools are included, recognizing that countries use different datamanagement systems for HMIS, so the CVD monitoring tools will be adapted to work with the HMIS system being used by the country, such that the indicators can be collected with minimal disruption/work to existing systems and tools more

Download (179)

View PDF (278)

HEARTS. Technical package for cardiovascular disease management in primary health care. Evidence-based treatment protocols

World Health Organization WHO, et al. (2018) C_WHO

In many low- and middle-income countries, there is a wide gap between evidencebased recommendations and current practice. Treatment of major CVD risk factors remains suboptimal, and only a minority of patients who are treated reach their target levels for blood pressure, blood sugar and blood choles... more

Download (675)

View PDF (1080)

Sexually Transmitted Diseases Treatment Guidelines, 2015. Pocket guide

Centers for Disease Control and Prevention (2015) CC

Download (1096)

View PDF (1531)

Oxygen therapy for children: a manual for health workers
recommended

World Health Organization WHO (2016) C_WHO

This manual focuses on the availability and clinical use of oxygen therapy in children in health facilities by providing the practical aspects for health workers, biomedical engineers, and administrators. It addresses the need for appropriate detection of hypoxaemia, use of pulse oximetry, clinical ... more

Download (1408)

View PDF (1268)

2014 PHA Clinical Practice Guidelines for the Diagnosis and Management of Patients with Coronary Artery Disease
recommended

Liberty O. Yaneza, Ma. Consolacion Dolor-Torres, Sue Ann R. Locnen Philippine Heart Association (2014) C1

Download (596)

View PDF (928)

Improving Health and Reducing Poverty. Disease Control Priorities, Third Edition : Volume 9.

Jamison, Dean T.; Gelband, Hellen; Horton, Susan, et al. World Bank (2017) CC

As the culminating volume in the DCP3 series, volume 9 will provide an overview of DCP3 findings and methods, a summary of messages and substantive lessons to be taken from DCP3, and a further discussion of cross-cutting and synthesizing topics across the first eight volumes. The introductory chapte... more

Download (1059)

View PDF (1498)

Clinical Practice Guidelines for the Management of Cryptococcal Disease: 2010 Update by the Infectious Diseases Society of America

John R. Perfect, William E. Dismukes, Francoise Dromer, et al. Infectious Diseases Society of America (2010)

Clinical Infectious Diseases 2010; 50:291–322

Download (2367)

View PDF (1392)

National Standard Therapeutic Guidelines and Essential Medicines List Liberia 2017, 2nd ed.
recommended

Republic of Libera, Ministry for Health and Social Welfare (2017) C1

Download (1009)

View PDF (2773)

National Treatment Guidelines for Antimicrobial Use in Infectious Diseases India
recommended

National Centre for Disease Control; Ministry of Health & Family Welfare India (2016) C1

Download (78)

View PDF (129)

Adverse events associated with use of Isoniazid preventive therapy among people living with HIV

World Health Organization (2015) C_WHO

Information note

Download (483)

View PDF (989)

Guidelines for diagnosing, preventing and managing cryptococcal disease among adults, adolescents and children living with HIV
recommended

World Health Organization (WHO) (2022) C_WHO

Cryptococcal disease is one of the most common opportunistic infections among people living with advanced HIV disease and is a major contributor to severe illness, morbidity, and mortality, particularly in sub-Saharan Africa. These guidelines update the recommendations that were first released i... more

Download (868)

View PDF (990)

Nepal National Antiretroviral Therapy Guidelines

National Centre for AIDS and STD Control (NCASC) Nepal (2009)

Download (232)

View PDF (235)

Guidelines for diagnosing, preventing and managing cryptococcal disease among adults, adolescents and children living with HIV. Policy brief
recommended

World Health Organization WHO (2022) C_WHO

Cryptococcal disease, particularly cryptococcal meningitis is a significant cause of morbidity and mortality among people living with HIV with advanced HIV disease. It is estimated that it is responsible for nearly 19% of AIDS-related mortality, second only to tuberculosis. Rapid screening, diagnosi... more

Download (144)

View PDF (218)

Chagas Disease: Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents with HIV

Panel on Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents with HIV Clinical Info HIV (2018) CC

Epidemiology Chagas disease (American trypanosomiasis) is caused by the protozoan parasite Trypanosoma cruzi, and transmitted to humans by infected triatomine bugs, and less commonly by transfusion, organ transplant, from mother to infant, and in rare instances, by ingestion of contaminated food or... more

Download (20)

View PDF (18)

Selection of essential medicines for the prevention and treatment of cardiovascular diseases in low and middle income countries

Bazargani, Y.T.; Ugurlu, M.; Leufkens, H.G.M. et al. BMC Cardiovascular Disorders (2018) CC

The incidence and mortality of cardiovascular diseases (CVDs) in low and middle income countries (LMICs) have been increasing, while access to CVDs medicines is suboptimal. We assessed selection of essential medicines for the prevention and treatment of CVDs on national essential medicines lists (NE... more

Download (20)

View PDF (26)

Global status report on noncommunicable diseases 2014 WHO

World Health Organization (WHO) World Health Organization (WHO) (2014) C_WHO

This global status report on prevention and control of NCDs (2014), is framed around the nine voluntary global targets. The report provides data on the current situation, identifying bottlenecks as well as opportunities and priority actions for attaining the targets. The 2010 baseline estimates on N... more

Download (23)

View PDF (20)

Appropriate use and withdrawal of inhaled corticosteroids (ICS) in patients with chronic obstructive pulmonary disease (COPD)

Román-Rodríguez, M.; Tsiligianni, I.; Wiliams, S.; et al. International Primary Care - Respiratory Group (2020) CC2

The document "Appropriate use and withdrawal of inhaled corticosteroids (ICS) in patients with chronic obstructive pulmonary disease (COPD)" from the IPCRG provides guidance on when to start, adjust, or discontinue ICS in COPD treatment. It highlights the benefits and risks, emphasizing personalized... more

Treatment of Mycobacterium Ulcerans Disease (Buruli Ulcer) recommended

Oxygen therapy for children: a manual for health workers recommended

2014 PHA Clinical Practice Guidelines for the Diagnosis and Management of Patients with Coronary Artery Disease recommended

National Standard Therapeutic Guidelines and Essential Medicines List Liberia 2017, 2nd ed. recommended

National Treatment Guidelines for Antimicrobial Use in Infectious Diseases India recommended

Guidelines for diagnosing, preventing and managing cryptococcal disease among adults, adolescents and children living with HIV recommended

Guidelines for diagnosing, preventing and managing cryptococcal disease among adults, adolescents and children living with HIV. Policy brief recommended